Enter Your Practice Information





Yes No

Yes No


X
x

Welcome to the all-new Vetlearn

  • Vetlearn is becoming part of NAVC VetFolio.
    Starting in January 2015, Compendium and
    Veterinary Technician articles will be available on
    NAVC VetFolio. VetFolio subscribers will have
    access to not only the journals, but also:
  • Over 500 hours of CE
  • Community forums to discuss tough cases
    and networking with your peers
  • Three years of select NAVC Conference
    Proceedings
  • Free webinars for the entire healthcare team

To access Vetlearn, you must first sign in or register.

registernow

  Sign up now for:
Become a Member

Journal June 2013 (Vol 35, No 6)

NOTE: You have already passed this course.
NOTE: This course is no longer valid for accreditation purposes.

Hepatic Encephalopathy: Diagnosis and Treatment by Melissa Salgado , DVM, Yonaira Cortes , DVM, DACVECC

1. Which factor can precipitate development of hepatic encephalopathy (HE) in an animal with a portosystemic shunt?
2. Which laboratory value, if significantly elevated in serum, does not correlate with HE?
3. Which of the following does not support a diagnosis of HE?
4. Lactulose can be an effective treatment for HE because it
5. Which statement is true with regard to antibiotic therapy in the treatment of HE?
6. Which statement regarding nutrition in patients with HE is false?
7. Mannitol decreases intracranial hypertension in HE patients by
8. L-Ornithine-L-aspartate therapy may be effective in treating HE because the drug
9. The Molecular Adsorbent Regenerating Systemdoes not lower plasma levels of
10. The clinical signs of intracranial hypertension associated with type A HE do not include
Stay on top of all our latest content — sign up for the Vetlearn newsletters.
  • More
Subscribe